To evaluate whether repetitive transcranial magnetic stimulation (RTMS
) may be used for speech localization, we compared the results from RT
MS with the intracarotid amobarbital test (IAT) in 21 patients undergo
ing surgical treatment (amygdalohippocampectomy or anterior temporal l
obe resection) for medically intractable partial epilepsy. None of the
patients had aphasia. We stimulated the temporal and frontal cortex o
n each side at a frequency of 30 Hz for 1 second and increased the int
ensity until speech was inhibited. A list of words and forward and bac
kward counting were used to test speech function. The IAT was performe
d on the hemisphere of proposed surgery by unilateral injection and si
multaneous regional cerebral blood flow (rCBF) recordings. In one pati
ent, there was doubt about hemisphere dominance and a second bilateral
IAT was performed. Fifteen patients had left-sided speech dominance;
one, left-sided dominance and a moderate right-sided speech inhibition
; two, right-sided speech dominance; and one, bilateral speech represe
ntations (bilateral injection at the IAT) with both techniques. One pa
tient showed bilateral with right-sided speech dominance by RTMS and s
howed right-sided speech inhibition with right-sided injection only at
the IAT procedure. One patient differed from the rest, showing bilate
ral representation with right-sided speech dominance with RTMS and lef
t-sided speech inhibition by IAT with left-sided injection only. The c
oncordance was 95%. None of the patients had seizures provoked by the
procedure. We conclude that speech localization with RTMS shows a high
concordance with the results from the IAT and may be useful in additi
on to traditional techniques in speech localization. RTMS is noninvasi
ve, can be repeated, carries little or no risks, and does not require
that the patients be hospitalized.